- Home
- SGHT vs RDCM Comparison
SGHT vs RDCM Comparison
Compare SGHT & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- RDCM
- Stock Information
- Founded
- SGHT 2011
- RDCM 1985
- Country
- SGHT United States
- RDCM Israel
- Employees
- SGHT 216
- RDCM N/A
- Industry
- SGHT Medical Specialities
- RDCM Computer peripheral equipment
- Sector
- SGHT Health Care
- RDCM Technology
- Exchange
- SGHT Nasdaq
- RDCM Nasdaq
- Market Cap
- SGHT 179.7M
- RDCM 210.6M
- IPO Year
- SGHT 2021
- RDCM 1997
- Fundamental
- Price
- SGHT $3.64
- RDCM $12.85
- Analyst Decision
- SGHT Buy
- RDCM Strong Buy
- Analyst Count
- SGHT 8
- RDCM 2
- Target Price
- SGHT $4.01
- RDCM $16.00
- AVG Volume (30 Days)
- SGHT 164.1K
- RDCM 72.0K
- Earning Date
- SGHT 07-31-2025
- RDCM 08-06-2025
- Dividend Yield
- SGHT N/A
- RDCM N/A
- EPS Growth
- SGHT N/A
- RDCM 111.69
- EPS
- SGHT N/A
- RDCM 0.53
- Revenue
- SGHT $78,109,000.00
- RDCM $63,477,000.00
- Revenue This Year
- SGHT N/A
- RDCM $18.09
- Revenue Next Year
- SGHT $11.60
- RDCM $11.46
- P/E Ratio
- SGHT N/A
- RDCM $24.10
- Revenue Growth
- SGHT N/A
- RDCM 18.21
- 52 Week Low
- SGHT $2.03
- RDCM $9.10
- 52 Week High
- SGHT $8.45
- RDCM $15.98
- Technical
- Relative Strength Index (RSI)
- SGHT 38.36
- RDCM 46.67
- Support Level
- SGHT $3.37
- RDCM $13.40
- Resistance Level
- SGHT $3.60
- RDCM $13.88
- Average True Range (ATR)
- SGHT 0.23
- RDCM 0.61
- MACD
- SGHT -0.12
- RDCM -0.07
- Stochastic Oscillator
- SGHT 8.21
- RDCM 32.94
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.